ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting
The Programs Committee is hard at work and invites you to save the date for the annual SIDP Business Meeting and Reception on October 10, 2023, at the Seaport Convention Center in Boston, MA, one day prior to the start of IDWeek 2023 (October 11-15, 2023 in Boston, MA). The Business Meeting will feature a keynote speaker, educational programming, and more! Social reception with light appetizers and beverages to follow. Further details and registration coming soon!
On February 8, 2023, USCAST spoke about the vision and future goals for USCAST and the 2023 in vitro susceptibility test interpretive criteria (STIC, also known as susceptibility breakpoints) recommendations.
STIC were reviewed for piperacillin/tazobactam against Enterobacterales and Pseudomonas aeruginosa, various agents against A. baumannii, and aminoglycosides against Enterobacterales and P. aeruginosa. All slide presentations and Zoom videos from these presentations are now posted on the USCAST website, http://www.uscast.org/. The USCAST STIC recommendations based on these presentations are now open for public comment for the next 60 days. This open public comment period will end on April 30, 2023.
USCAST encourages all interested parties to review the presentations and to provide feedback on the content, recommendations, and process for evaluation for the topics presented via the USCAST website. Feedback that is received will be reviewed and considered prior to the finalization of STIC recommendations. They also welcome suggestions about potential pathogen/drug combinations for future evaluation.
USCAST values your input and looks forward to hearing from you!
Reports of infections with an extensively drug-resistant strain of Verona Integron-mediated Metallo-βlactamase (VIM) and Guiana-Extended Spectrum-β-Lactamase (GES)-producing carbapenem-resistant Pseudomonas aeruginosa in 12 states.
Check out the full advisory from the CDC for more information.
Pharmacists are often sought out for opinions on drug efficacy and shortages in the news, and our awesome SIDP crew is no exception!
Check out SIDP’s past presidents Kerry LaPlante and Jason Gallagher, and president-elect Sam Aitken speaking to how our current shortages with liquid amoxicillin are impacting patient care and how access is key to solving these shortages.
Their articles can be found here:
The survey included ID Pharmacists and Physicians and found that 90% of them considered antimicrobial resistance to be a "major problem". Check out the full story here!
Pharmacies across the United States are reporting a shortage of oral amoxicillin suspension. The shortage is evolving and may extend to other oral formulations. The FDA reports the shortage may be in part, due to increased demand. This coincides with a rise in the number of children sick and or/hospitalized with respiratory viral infections, such as RSV and influenza. Though supportive care is the mainstay of treatment for viral infections, antibiotics may be indicated for the treatment of superimposed bacterial infections, including pneumonia and acute otitis media. While alternative antibiotics may be available depending on the indication, many have a broader spectrum of activity, increased toxicity, and excess cost relative to amoxicillin. Furthermore, it is anticipated alternatives may soon become in short supply as well, given increased usage.
The Society of Infectious Diseases Pharmacists (SIDP) encourages the judicious use of antibiotics, including prescribing antibiotics only when bacterial infections are confirmed or strongly suspected. SIDP also supports the use of the shortest, effective duration of therapy, along with watch-and-wait strategies when appropriate.
Since respiratory viruses, such as RSV and Influenza, spread through respiratory droplets, SIDP suggests following appropriate precautions to reduce spread by handwashing, covering coughs/sneezes, and avoiding close contact with sick people. SIDP also suggests up-to-date vaccination for respiratory viral illnesses, including influenza and COVID-19.
Antibiotic Awareness Week is November 18-24, 2022. We invite patients and health care providers to join us in fighting against antimicrobial resistance and in optimizing use of antibiotics through antimicrobial stewardship by viewing available resources on our website at: https://sidp.org/Antibiotic-Awareness-Week.
The SIDP Programs Committee and Board of Directors are excited to announce Dr. Ilisa Bernstein, PharmD, JD, FAPhA, Interim CEO and Executive Vice President of the American Pharmacists Association (APhA) as the keynote speaker for the 2022 Annual Business Meeting. Dr. Bernstein will present, “A Seat at the Table: Advocating for ID Pharmacy.”
The business meeting will be held at the Walter E. Washington Convention Center in Washington D.C from 2:30-6 p.m. EST on October 18, 2022, one day prior to the start of the live IDWeekTM 2022 meeting. A reception with socialization, light appetizers, and beverages will immediately follow the business meeting from 6-9 p.m. EST. More information can be found at SIDP - Annual Meetings.
Additionally, we are pleased to announce a virtual option to attend the business meeting for those who are unable to attend in person. Please visit SIDP - 2022 SIDP Annual Business Meeting and Reception to register as a virtual attendee prior to October 18, 2022.
SIDP is assisting the Society for Healthcare Epidemiology of America (SHEA) in identifying nominations for an associate editor for the Antimicrobial Stewardship and Healthcare Epidemiology (ASHE) journal.
SIDP is proposing the appointment of an SIDP member who is middle or advanced career for this position. ASHE focuses on practice-based, clinical research, including antimicrobial stewardship, prevention of healthcare-associated infections, and other areas of quality improvement affecting health systems, with the goal of improving healthcare safety. The associate editor, if appointed, should have clinical and research experience, specifically in this space.
SIDP will forward the name of the recommended candidate to the Editor-in-Chief (EIC) of ASHE for consideration. The EIC is responsible for appointment of the associate editor, the name of whom is then submitted to the SHEA Board of Directors to be ratified.
Interested members should submit a statement of interest, CV, and three blinded peer reviews by Friday, June 24, 2021. Blinded peer reviews should only contain the feedback sent and not the original manuscript; author and title names should be struck from submitted documents. The committee will evaluate candidates' publication record in peer-reviewed journals and peer review experience. The number of peer reviews completed and a list of journals by name for whom the candidate has reviewed papers in the last 2 years should be clearly available in either the CV or statement of interest.
SIDP, SHEA, and ASHE are committed to represent diverse interests and viewpoints. We encourage candidates to share any unique perspectives they have that would facilitate their role and expand the purview of ASHE.
Interested candidates should submit their application materials and any questions to the Chair of Publications and Podcasts committee, Rachel Britt, firstname.lastname@example.org.
Candidate Scoring Guide
Diverse representation - geographic (i.e., resource-limited practice), work with special populations, candidate part of minoritized community or group (including but not limited to LGBTIQA+, race/ethnicity, gender), unique or significant service
6 points for applicant’s practice; 4 points for applicant
Experienced reviewer for significant journals (in the past 2 years since Jan 2020)
Research – CID, OFID, JAC, AAC, ICHE
Education – AJPE, AM, ME, ASHE
Members of the SIDP Public Outreach Committee recently published an editorial in the Journal of the American College of Clinical Pharmacy on pharmacists’ role in antimicrobial stewardship (ASP) interventional research.
Most healthcare institutions in the U.S. rely on pharmacy services to develop and expand ASP initiatives. In 2019, members of the committee sought to characterize trends in ASP interventional research. Using PubMed to identify studies evaluating the impact of an ASP intervention from 1990-2019 in North America, SIDP found that the frequency of pharmacist authorship has been increasing over the last twenty years. Overall, two-thirds of publications included a pharmacist as an author. A subset of one-hundred studies was further reviewed for intervention type, outcomes of interest, study setting, population, and descriptive methodology. The findings of this report informed the following recommendations and opportunities for expansion in ASP interventional research:
The second annual Infectious Diseases Pharmacists Day will be held on Sunday, May 22, 2022. This day recognizes the importance of ID pharmacists in promoting appropriate antimicrobial use and the contributions they make to patient care, education, and research. This year’s theme is deprescribing antibiotics in COVID-19. Please check out the SIDP - Infectious Diseases Pharmacists Day website for opportunities to show your support, including a Twitter Storm, access to the Advocacy tool kit, and Share Your Story to be featured on our social media pages. We look forward to an exciting virtual turn out!
Society of Infectious Diseases Pharmacists • 403 W. Saint Charles, Suite B, Lombard, IL 60148
(331) 248-7888 • email@example.com
Proudly Managed by Affinity Strategies